India to make 300 million doses of the Russian vaccine

RUSSIA / FSU POLITICS - In Brief 14 Jul 2021 by Alex Teddy
On July 13 Moscow announced a deal with Serum Institute to make Sputnik V. The first doses will produced in September 2021. The Russian Direct Investment Fund is behind Sputnik V. Russia is delighted with the uptake of Sputnik V seeing it as a soft power victory. It is also a financial gain. Selling to India is significant. The two countries have always had a cordial relationship. Sputnik V has been approved in 67 countries. Technology to make the vaccine has been sent to India. India has struggled with Delta variant.The EU has still not approved Sputnik V although some EU member states have.

Now read on...

Register to sample a report

Register
Sign-in
Forgot your password?
Copyright 2024 GlobalSource Partners. All rights reserved. This is prepared for GlobalSource Partners’ clients and may not be redistributed, reproduced, stored in a retrieval system, retransmitted or disclosed, in whole or in part, or in any form or manner, without the express written consent of GlobalSource Partners. This is distributed simultaneously to our website and other portals used by GlobalSource Partners. The information herein was obtained from various sources and is believed to be reliable but GlobalSource Partners does not warrant its completeness or accuracy. Neither GlobalSource Partners nor any Country Analyst, officer or employee accepts any liability whatsoever for any direct, indirect or consequential damages or losses rising from any use of this or its contents.